Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 05.04.2024
InCity Immobilien AG
Schönefeld, 5. April 2024: In the past fiscal year 2023, InCity Immobilien AG (“InCity AG”) generated a consolidated net loss for the year (pursuant to the German Commercial Code, HGB) of approximately EUR 6.0 m, based on unaudited preliminary figures. This falls below the earnings forecast, which was revised last December and posited a consolidate [ … ]
Fri, 05.04.2024
The Platform Group AG
The Platform Group AG publishes preliminary figures for 2023
Düsseldorf, 05 April 2024. The Platform Group AG (ISIN DE000A200QEFA1, „TPG“), has achieved or exceeded its forecasts for the 2023 financial year. The pro-forma gross merchandise volume (GMV, continuing operations) increased to 705 million euros (2022: 591 million euros, forecast: 700 mil [ … ]
Fri, 05.04.2024
Edison Investment Research Limited
London, UK, 5 April 2024
Edison issues initiation on AUSTRIACARD (ACAG): Holding a strong hand
AUSTRIACARD has a long heritage of providing secure services for smart card provision and document management in Europe. It has expanded its portfolio organically and through acquisition to encompass digital transformation technology and a strong [ … ]
Fri, 05.04.2024
APONTIS PHARMA AG
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast
Monheim / Rhein, 5 April 2024. APONTIS PHARMA AG (Ticker APPH / ISIN DE000A3CMGM5) has entered into a five-year agreement with Novartis Pharma GmbH to take over the distribution and marketing of the patent-protected medi [ … ]
Fri, 05.04.2024
APONTIS PHARMA AG
Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement with Novartis for two asthma medications
Monheim / Rhein, 5 April 2024. APONTIS PHARMA AG (“APONTIS PHARMA” or the “Company”, Ticker APPH / ISIN DE000A3CMGM5) ha [ … ]
Fri, 05.04.2024
Thai Cement Manufacturers Association (TCMA)
EQS Newswire / 05/04/2024 / 10:00 CET/CEST
"Dr. Chana Poomee" Chairman of Thai Cement Manufacturers Association (TCMA), announced the vision of 'TCMA Synergizing the Actions toward Net Zero 2050, to drive the cement industry, join forces in all sectors, upgrade industry energy transition with innovation, connect global green funds to realize Ne [ … ]
Fri, 05.04.2024
neurocare group AG
neurocare group AG Welcomes Norman Erhard as Senior VP Europe & Latin America
Munich, Germany, 05. April 2024 - neurocare group AG (“neurocare” or the “Company”), a leading innovator in personalized mental health and performance empowering clinicians to deliver best practice is pleased to announce the appointment of Norman Erhard as Senior Vic [ … ]
Fri, 05.04.2024
Electrip Global
EQS-Media / 05.04.2024 / 09:40 CET/CEST
ZES and electrip; joint ventures of Zorlu Enerji & WrenHouse established under Electrip Global Ltd and Hubject, the world's largest charging network provider, have signed a partnership to enhance e-roaming solutions.
Amsterdam - ZES, as one of Turkey's leading charge point operators (CPO); and elect [ … ]
Fri, 05.04.2024
Electrip Global
EQS-Media / 05.04.2024 / 09:40 CET/CEST
ZES and electrip; joint ventures of Zorlu Enerji & WrenHouse established under Electrip Global Ltd and Hubject, the world's largest charging network provider, have signed a partnership to enhance e-roaming solutions.
Amsterdam - ZES, as one of Turkey's leading charge point operators (CPO); and elect [ … ]
Fri, 05.04.2024
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma to host R&D Webinar following novel data presented at AACR
Ladenburg, Germany, 5 April 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), is pleased to announce that it will be hosting an R&D Webinar on 23 April 2024 at 16.00 CEST [ … ]